首页> 外文期刊>EJVES Short Reports >Applied Machine Learning for the Prediction of Growth of Abdominal Aortic Aneurysm in Humans
【24h】

Applied Machine Learning for the Prediction of Growth of Abdominal Aortic Aneurysm in Humans

机译:应用机器学习预测人类腹主动脉瘤的生长

获取原文
       

摘要

Objective Accurate prediction of abdominal aortic aneurysm (AAA) growth in an individual can allow personalised stratification of surveillance intervals and better inform the timing for surgery. The authors recently described the novel significant association between flow mediated dilatation (FMD) and future AAA growth. The feasibility of predicting future AAA growth was explored in individual patients using a set of benchmark machine learning techniques. Methods The Oxford Abdominal Aortic Aneurysm Study (OxAAA) prospectively recruited AAA patients undergoing the routine NHS management pathway. In addition to the AAA diameter, FMD was systemically measured in these patients. A benchmark machine learning technique (non-linear Kernel support vector regression) was applied to predict future AAA growth in individual patients, using their baseline FMD and AAA diameter as input variables. Results Prospective growth data were recorded at 12 months (360?±?49 days) in 94 patients. Of these, growth data were further recorded at 24 months (718?±?81 days) in 79 patients. The average growth in AAA diameter was 3.4% at 12 months, and 2.8% per year at 24 months. The algorithm predicted the individual's AAA diameter to within 2?mm error in 85% and 71% of patients at 12 and 24 months. Conclusions The data highlight the utility of FMD as a biomarker for AAA and the value of machine learning techniques for AAA research in the new era of precision medicine. Highlights ? Flow mediated dilatation of brachial artery is a biomarker of AAA progression. ? It is feasible to predict future AAA growth in individuals using machine learning techniques. ? Endothelial dysfunction is a key feature in human AAA disease.
机译:目的准确预测个体的腹主动脉瘤(AAA)的生长情况,可以实现监视间隔的个性化分层,并更好地告知手术时机。作者最近描述了流量介导的扩张(FMD)与未来AAA生长之间的新型显着关联。使用一组基准机器学习技术探讨了预测个别患者未来AAA增长的可行性。方法牛津腹主动脉瘤研究(OxAAA)前瞻性招募接受常规NHS管理途径的AAA患者。除AAA直径外,还对这些患者进行了口蹄疫测量。应用基准机器学习技术(非线性内核支持向量回归),以患者的基线FMD和AAA直径作为输入变量来预测未来患者中AAA的增长。结果94例患者在12个月(360±±49天)时记录了预期的生长数据。其中,有79例患者在24个月(718±±81天)时进一步记录了生长数据。 AAA直径的平均增长在12个月时为3.4%,在24个月时为每年2.8%。该算法预测,在12和24个月时,分别有85%和71%的患者的AAA直径误差在2?mm以内。结论数据突显了FMD作为AAA生物标志物的实用性,以及机器学习技术在精确医学新时代对AAA研究的价值。强调 ?流量介导的肱动脉扩张是AAA进展的生物标志。 ?使用机器学习技术预测个人未来AAA的增长是可行的。 ?内皮功能障碍是人类AAA疾病的关键特征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号